Rituximab for treatment of inhibitors in haemophilia A. A Phase II study.
Leissinger C, Josephson CD, Granger S, Konkle BA, Kruse-Jarres R, Ragni MV, Journeycake JM, Valentino L, Key NS, Gill JC, McCrae KR, Neufeld EJ, Manno C, Raffini L, Saxena K, Torres M, Marder V, Bennett CM, Assmann SF. Rituximab for treatment of inhibitors in haemophilia A. A Phase II study. Thromb Haemost. 2014 Sep 02; 112(3):445-58.
-
Adolescent
-
Adolescent
-
Adult
-
Adult
-
Antibodies, Blocking
-
Antibodies, Blocking
-
Antibodies, Monoclonal, Murine-Derived
-
Antibodies, Monoclonal, Murine-Derived
-
Antibody Formation
-
Antibody Formation
-
Antigens, CD20
-
Antigens, CD20
-
Blood Coagulation
-
Blood Coagulation
-
Child
-
Child
-
Child, Preschool
-
Child, Preschool
-
Factor VIII
-
Factor VIII
-
Follow-Up Studies
-
Follow-Up Studies
-
Hemophilia A
-
Hemophilia A
-
Humans
-
Humans
-
Immunosuppressive Agents
-
Immunosuppressive Agents
-
Male
-
Male
-
Rituximab
-
Rituximab
-
Treatment Outcome
-
Treatment Outcome
-
United States
-
United States
-
Young Adult
-
Young Adult